The All India Drugs Control Officers Confederation (AIDCOC) has demanded that the Union health ministry suspend the approval granted to 33 drugs for sale in India with immediate effect, as the approval was given without conducting the required clinical ...

NEW DELHI: German drugmaker Bayer AG has demanded the withdrawal of the country's first compulsory licence given to Natco Pharma, arguing that a three-fourth reduction in the price of the anti-cancer drug by another Indian firm has made the permit ...

By RUMMAN AHMED BANGALORE—India's government is facing stiff resistance from foreign and local pharmaceutical companies over its plan to severely limit prices for drugs.

CAPE TOWN-based pharmaceuticals distributor Cipla Medpro - which specialises in generic applications - is starting to build impressive critical mass with its revenue nearing the R1.8 billion mark in the year to end December 2011.

Cipla has rolled out an aggressive strategy to elbow out new competitors like Lupin and Glenmark in the anti asthma segment. Bloomberg UTV learns the company is offering incentives over and above margins to garner more shelf space.